MHRA-100754-PIP01-22-M01 (update)

Key Facts

PIPS Key Facts
Active Substance
Active Substance:
  • Live-attenuated La Reunion strain of chikungunya virus
Invented Name
Not yet available
PIP Number MHRA-100754-PIP01-22-M01 (update)
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Powder and solvent for suspension for injection
Therapeutic area
Therapeutic area:
  • Vaccines
Conditions / Indications
Conditions / Indications:
  • Prevention of chikungunya virus disease
Route(s) of administration
Route(s) of administration:
  • Intramuscular use
PIP applicant
Decision Type
Decision Type
PM: decision on the application for modification of an agreed paediatric investigation plan.
Compliance Check
Compliance Check
Compliance Check Decision Date
Compliance opinion date
Compliance Check Procedure Number
Compliance procedure number

Decision Document

PIPS Decision Documents
Decision Document Decision Document on a Paediatric Investigation Plan (PIP):Live-attenuated La Reunion strain of chikungunya virus .pdf
Published Date 24/06/2024